Stock Chart

CNTA

$40.50 +0.80%
Score: 48.2 HOLD
LEAPs: SELL $40
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $40
Premium: $5.16
Expiry: Dec 18, 2026
Target: $40
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 6.50x (vs SPY: 6.1x | vs QQQ: 6.0x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Jun 23, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About CNTA - Centessa Pharmaceuticals plc American Depositary Shares

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Key Statistics

Market Cap $6B

More CNTA Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This CNTA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track CNTA's price movements with trendlines, gamma walls, and key support/resistance levels.